• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld

BioWorld

July 15, 2016

View Archived Issues

PARPs for course: BRCA test advancing, handful of players push research

A simplified way of making BRCA mutation testing available for women with ovarian cancer (OC) – a handier procedure that makes results available quicker, pioneered by researchers at the Institute of Cancer Research in London – comes just as competition heats up among drug developers. Read More

Study: Regenerative med pipeline strong but reimbursement challenges loom

A strong development pipeline for regenerative medicine (RM) therapies designed to treat a range of unmet medical needs suggests the potential for rapid growth in global sales of products that could offer significant benefits to public health, according to an analysis by the Tufts Center for the Study of Drug Development (CSDD). Read More

CARA to become law, opening the door to addiction treatment

Recognizing opioid addiction as a disease to be treated rather than a crime to be punished, the U.S. Senate overwhelmingly passed the final version of the Comprehensive Addiction and Recovery Act (CARA) Wednesday on a vote of 92-2, sending it to the president for his signature. Read More

China's PMI moving forward; NHFPC names 61 projects for funding

HONG KONG – China's multibillion-dollar precision medicine initiative is shaping up with a nearly ¥642 million (US$96 million) investment for 61 key projects ready to go. Read More

Financings

Galena Biopharma Inc., of San Ramon, Calif., closed its registered direct offering of 28 million common shares to undisclosed institutional investors. Read More

Other news to note

Eisai Inc., of Woodcliff Lake, N.J., and Arena Pharmaceuticals Inc., of San Diego, said Mexican regulators granted approval of weight management drug Venespri (lorcaserin HCl) for commercialization, by Eisai Laboratorios S. de R.L. de C.V., as an adjunct to a reduced-calorie diet and increased physical activity in adults with a body mass index of 30 kg/m2 or greater. Read More

Appointments and advancements

Neuroderm Ltd., of Rehovot, Israel, named Tami Yardeni chief operating officer and Eran Shor vice president, devices. Read More

In the clinic

Beyondspring Pharmaceuticals Inc., of New York, said the FDA notified the company that the phase I/II study with Opdivo (nivolumab, Bristol-Myers Squibb Co.) in combination with plinabulin for patients with metastatic non-small-cell lung cancer may proceed with enrolling patients. Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • U.S. Capitol building, Washington D.C.

    House passes H.R. 1, restoring R&D tax cuts

    BioWorld MedTech
    The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe